BACKGROUND: Chemical pleurodesis using videothoracoscopically applied powdered talc under general anaesthesia and selective pulmonary ventilation is the most effective method of palliative therapy for malign pleural exudate. Talc produces an intense systemic inflammatory reaction with the development of aseptic pleurisy. The result is obliteration of the pleural cavity provided there is an intense inflammatory reaction in the pleural cavity and good contact of both pleural leaves. The course of the adherence of pleural leaves can be followed using skiascopy. In routine practice, the course of local inflammatory markers is difficult to evaluate. Selection of suitable patients who will respond to this procedure is another principal obstacle of this surgical method. AIM: To evaluate the course of local inflammatory changes in the pleural cavity following application of talc and to quantify their dynamics. Selection of specific biomarkers to predict the intensity of inflammation in the pleural exudate for targeted selection of patients suitable for talcage was the second aim of this study. MATERIALS AND METHODS: 114 patients were retrospectively divided into Group A (N1 = 98) or patients without relapse and Group B (N2 = 16), patients with relapse of exudate formation. The need for repeated thoracic punctures or drainage over the course of a 12-month monitoring period was a criterion of treatment failure. Quantification of the effusion was performed by ultrasonic examination over a one year observational period at 3-monthly intervals. The concentration of soluble CD163 scavenger receptor and soluble Apo/Fas molecule was determined in exudate by ELISA. RESULTS: Soluble receptors in the 2 groups differed significantly. Group B showed higher sCD163 levels before talcage (P0 = 0.00024), faster dynamic decline in 2 h (P2 = 0.0092) and in 24 h (P24 = 0.0087). During monitoring, decrease in group B was statistically significant at 2 h (P2 = 0.056) and at 24 hrs (P24 = 0.0066). CONCLUSION: This pilot study showed that high values of sCD163 and sApo/Fas in the pleural exudate can predict treatment failure. Unsuitable candidates for this type of therapy couldbe selected in this way.

Department of Cardiac Surgery Faculty of Medicine in Hradec Kralove Charles University Prague and University Hospital in Hradec Kralove Czech Republic

Department of Clinical Immunology and Allergy Faculty of Medicine in Hradec Kralove Charles University Prague and University Hospital in Hradec Kralove

000      

00000naa a2200000 a 4500

001      

bmc17004333

003      

CZ-PrNML

005      

20170308085102.0

007      

ta

008      

170127s2015 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.5507/bp.2015.005 $2 doi

024    7_

$a 10.5507/bp.2015.005 $2 doi

035    __

$a (PubMed)25690520

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Habal, Petr $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic $7 xx0063394

245    10

$a New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate / $c P. Habal, N. Omran, J. Chek, J. Krejsek, J. Mandak

520    9_

$a BACKGROUND: Chemical pleurodesis using videothoracoscopically applied powdered talc under general anaesthesia and selective pulmonary ventilation is the most effective method of palliative therapy for malign pleural exudate. Talc produces an intense systemic inflammatory reaction with the development of aseptic pleurisy. The result is obliteration of the pleural cavity provided there is an intense inflammatory reaction in the pleural cavity and good contact of both pleural leaves. The course of the adherence of pleural leaves can be followed using skiascopy. In routine practice, the course of local inflammatory markers is difficult to evaluate. Selection of suitable patients who will respond to this procedure is another principal obstacle of this surgical method. AIM: To evaluate the course of local inflammatory changes in the pleural cavity following application of talc and to quantify their dynamics. Selection of specific biomarkers to predict the intensity of inflammation in the pleural exudate for targeted selection of patients suitable for talcage was the second aim of this study. MATERIALS AND METHODS: 114 patients were retrospectively divided into Group A (N1 = 98) or patients without relapse and Group B (N2 = 16), patients with relapse of exudate formation. The need for repeated thoracic punctures or drainage over the course of a 12-month monitoring period was a criterion of treatment failure. Quantification of the effusion was performed by ultrasonic examination over a one year observational period at 3-monthly intervals. The concentration of soluble CD163 scavenger receptor and soluble Apo/Fas molecule was determined in exudate by ELISA. RESULTS: Soluble receptors in the 2 groups differed significantly. Group B showed higher sCD163 levels before talcage (P0 = 0.00024), faster dynamic decline in 2 h (P2 = 0.0092) and in 24 h (P24 = 0.0087). During monitoring, decrease in group B was statistically significant at 2 h (P2 = 0.056) and at 24 hrs (P24 = 0.0066). CONCLUSION: This pilot study showed that high values of sCD163 and sApo/Fas in the pleural exudate can predict treatment failure. Unsuitable candidates for this type of therapy couldbe selected in this way.

650    _2

$a senioři $7 D000368

650    _2

$a biologické markery $x metabolismus $7 D015415

650    _2

$a exsudáty a transsudáty $x metabolismus $7 D005122

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a nádory plic $x komplikace $7 D008175

650    _2

$a lymfom $x komplikace $7 D008223

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a mezoteliom $x komplikace $7 D008654

650    _2

$a lidé středního věku $7 D008875

650    _2

$a paliativní péče $x metody $7 D010166

650    12

$a výběr pacientů $7 D018579

650    _2

$a pleurální dutina $7 D035422

650    _2

$a maligní pleurální výpotek $x etiologie $x terapie $7 D016066

650    _2

$a pleuritida $x chemicky indukované $7 D010998

650    _2

$a pleurodéza $x škodlivé účinky $x metody $7 D018700

650    _2

$a retrospektivní studie $7 D012189

650    _2

$a mastek $x aplikace a dávkování $x škodlivé účinky $7 D013627

650    _2

$a výsledek terapie $7 D016896

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Omran, Nedal $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic $7 xx0236392

700    1_

$a Chek, James Lago $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic $7 _AN053957

700    1_

$a Krejsek, Jan, $u Department of Clinical Immunology and Allergy, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove $d 1958- $7 nlk19990073429

700    1_

$a Manďák, Jiří, $u Department of Cardiac Surgery, Faculty of Medicine in Hradec Kralove, Charles University in Prague and University Hospital in Hradec Kralove, Czech Republic $d 1958- $7 mzk2006337422

773    0_

$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 4 (2015), s. 576-581

856    41

$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu

910    __

$a ABA008 $b A 1502 $c 958 $y 4 $z 0

990    __

$a 20170127 $b ABA008

991    __

$a 20170307095643 $b ABA008

999    __

$a ok $b bmc $g 1192548 $s 964949

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 159 $c 4 $d 576-581 $e 20150210 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606

LZP    __

$b NLK118 $a Pubmed-20170127